别名：Growth/differentiation factor 2; GDF2; GDF-2;BMP9; HHT5
基本信息：
| 表达系统 | 种属 | 内毒素 | 纯度 | 标签 |
| HEK293 | Human | ≤0.01 EU/μg | ≥95% | Tag free |
| Source | HEK 293 |
| Description
|
Human BMP-9 (Ser320-Arg429)
Accession # Q9UK05 |
| Predicted molecular mass | 12.1 kDa (monomer) |
| Appearance | White powder,Colorless clear liquid after reconstitution |
| Purity | ≥95%, by SDS-PAGE (under reducing (R)&Non-reducing conditions,visualized by Coomassie staining) |
| Endotoxin | ≤0.01EU/μg by the LAL method |
| Activity | Determined by its ability to induce alkaline phosphatase production by ATDC-5 cells. The expected ED50 for this effect is ＜2.0 ng/ml. |
| Formulation | Lyophilized from a 0.22 μm-filtered solution containing 0.085% TFA,30% ACN,5% Mannitol, pH 2.5 |
| Reconstitution | It is recommended to redissolve in 4mM HCl. |
| Shipping | Wet ice (seasonal) |
| Storage&Stability
|
36 months at -20°C to -80°C in lyophilized state
6 months at -20°C to -80°C under sterile conditions after reconstitution 7-10 days at 2°C to 8°C under sterile conditions after reconstitution Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
数据展示：
Bioactivity
Determined by its ability to induce alkaline phosphatase production by ATDC-5 cells.
The expected ED50 for this effect is ＜2.0 ng/ml.
The activity of recombinant Human BMP9(Cat. No. MGC008) is higher than the other competing product.